Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.
Clinical trial NCT03217838 · TERMINATED
Trial details
- NCT number
- NCT03217838
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2021-03-25
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.